What causes chemosis of the eye?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Chemosis of the eye is primarily caused by fluid accumulation in the conjunctiva, often resulting from allergic reactions, eye infections, trauma, or systemic conditions, as supported by the most recent evidence from 2024 1. The causes of chemosis can be diverse, including:

  • Allergic reactions to substances like pollen, pet dander, or certain medications
  • Eye infections such as bacterial or viral conjunctivitis
  • Trauma to the eye
  • Excessive eye rubbing
  • Systemic conditions like thyroid eye disease or angioedema
  • Post-eye surgery complications
  • Contact lens irritation
  • Environmental irritants The swelling occurs due to inflammatory mediators causing blood vessels in the conjunctiva to become more permeable, allowing fluid to leak into the surrounding tissue, as described in the context of atopic eye disease 1. It is essential to identify and address the underlying cause of chemosis, as it may indicate more serious conditions such as orbital cellulitis or cavernous sinus thrombosis, and treatment may include antihistamines for allergies, antibiotics for bacterial infections, or corticosteroids for severe inflammation, as noted in the management of conjunctivitis 1. In cases of severe disease, such as adenoviral keratoconjunctivitis with marked chemosis, topical corticosteroids may be helpful in reducing symptoms and scarring, but close follow-up is warranted due to potential adverse treatment effects 1. Overall, the management of chemosis depends on the underlying cause and may involve a range of treatments, from topical medications to more invasive procedures, as discussed in the context of dry eye syndrome and ocular surface disorders 1.

From the FDA Drug Label

Ocular adverse reactions occurring in 5-15% of patients treated with loteprednol etabonate ophthalmic suspension (0.2-0. 5%) in clinical studies included abnormal vision/blurring, burning on instillation, chemosis, discharge, dry eyes, epiphora, foreign body sensation, itching, injection, and photophobia.

The cause of chemosis of the eye is not explicitly stated in the drug label as being directly related to a specific factor, but it is listed as an ocular adverse reaction that occurred in 5-15% of patients treated with loteprednol etabonate ophthalmic suspension 2.

From the Research

Causes of Chemosis of the Eye

Chemosis of the eye can be caused by various factors, including:

  • Excess fluid in the conjunctiva, which can lead to conjunctival edema 3
  • Postoperative lymphatic dysfunction, periorbital edema, and exposure after cosmetic lower blepharoplasty 4
  • Allergic reactions, such as allergic conjunctivitis, which can be caused by airborne allergens, topical and systemic drugs, cosmetics, or animal hairs 5
  • Medication side effects, such as those associated with amlodipine besylate (Norvasc) 6
  • Surgical complications, such as those occurring after lower eyelid blepharoplasty 4, 7

Types of Chemosis

Different types of chemosis can occur, including:

  • Acute mild chemosis with complete lid closure (type 1) 4
  • Acute severe chemosis that prohibits complete lid closure (type 2) 4
  • Subchronic chemosis that persists longer than 3 weeks (type 3) 4
  • Chemosis associated with lower lid malposition (type 4) 4
  • Chronic localized conjunctival chemosis (CLCC), which can result from scarring and structural alteration of conjunctival lymphatics 3

Associated Factors

Associated factors that can contribute to chemosis include:

  • Conjunctival exposure 4
  • Periorbital and facial edema 4
  • Lymphatic dysfunction 4
  • Systemic conditions, such as essential hypertension 6
  • Local or systemic medical problems 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Allergic Conjunctivitis: An Update.

Handbook of experimental pharmacology, 2022

Research

Management of postblepharoplasty chemosis.

Aesthetic surgery journal, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.